Chemically-induced oxidative stress increases the vulnerability of PC12 cells to rotenone-induced toxicity

NeuroToxicology

Volumn 43, Issue , 2014, Pages 102-109

  de Groot, Martje W G D M ^a   Westerink, Remco H S ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Dexamethasone; Iron; L DOPA; Oxidative stress; Synuclein

Indexed keywords

ALPHA SYNUCLEIN; CALCIUM ION; DEXAMETHASONE; IRON; LEVODOPA; REACTIVE OXYGEN METABOLITE; ROTENONE; ANTIPARKINSON AGENT; CALCIUM; FERROUS ION; INSECTICIDE; FERROUS SULFATE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CELL STRESS; CELL VIABILITY; CHEMICAL STRESS; CONTROLLED STUDY; DISEASE PREDISPOSITION; FLUORESCENCE IMAGING; IN VITRO STUDY; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PC12 CELL LINE; POLLUTANT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANALYSIS OF VARIANCE; ANIMAL; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; TIME; BIOCHEMISTRY; CYTOTOXICITY; TOXICITY TESTING;

ALPHA-SYNUCLEIN; ANALYSIS OF VARIANCE; ANIMALS; ANTIPARKINSON AGENTS; CALCIUM; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FERROUS COMPOUNDS; INSECTICIDES; LEVODOPA; OXIDATIVE STRESS; PC12 CELLS; RATS; ROTENONE; TIME FACTORS;

EID: 84905912109     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2014.02.008     Document Type: Article

References (44)

1. Alberio T., Lopiano L., Fasano M. Cellular models to investigate biochemical pathways in Parkinson's disease. FEBS J 2012, 279:1146-1155.
2. Almeida M., Han L., Ambrogini E., Weinstein R.S., Manolagas S.C. Glucocorticoids and tumor necrosis factor alpha increase oxidative stress and suppress Wnt protein signaling in osteoblasts. J Biol Chem 2011, 286:44326-44335.
3. Asanuma M., Miyazaki I., Ogawa N. Dopamine- or l-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease. Neurotox Res 2003, 5:165-176.
4. Bolognin S., Messori L., Zatta P. Metal ion physiopathology in neurodegenerative disorders. Neuromol Med 2009, 11:223-238.
5. Castano A., Herrera A.J., Cano J., Machado A. The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-alpha, IL-1beta and IFN-gamma. J Neurochem 2002, 81:150-157.
6. Caudle W.M., Guillot T.S., Lazo C.R., Miller G.W. Industrial toxicants and Parkinson's disease. Neurotoxicology 2012, 33:178-188.
7. Chadwick W., Zhou Y., Park S.S., Wang L., Mitchell N., Stone M.D., et al. Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responses. PLoS ONE 2010, 5:e14352.
8. Cookson M.R. alpha-Synuclein and neuronal cell death. Mol Neurodegener 2009, 4:9.
9. Double K.L., Gerlach M., Youdim M.B., Riederer P. Impaired iron homeostasis in Parkinson's disease. J Neural Transm Suppl 2000, 60:37-58.
10. Elhamdani A., Brown M.E., Artalejo C.R., Palfrey H.C. Enhancement of the dense-core vesicle secretory cycle by glucocorticoid differentiation of PC12 cells: characteristics of rapid exocytosis and endocytosis. J Neurosci 2002, 20:2495-2503.
11. Freire C., Koifman S. Pesticide exposure and Parkinson's disease: epidemiological evidence of association. Neurotoxicology 2012, 33:947-971.
12. Gandhi S., Abramov A.Y. Mechanism of oxidative stress in neurodegeneration. Oxid Med Cell Longev 2012, 2012:428010.
13. Gao H.M., Liu B., Zhang W., Hong J.S. Novel anti-inflammatory therapy for Parkinson's disease. Trends Pharmacol Sci 2003, 24:395-401.
14. Greene L.A., Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 1976, 73:2424-2428.
15. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985, 260:3440-3450.
16. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J Neurochem 2006, 97:1634-1658.
17. Hendriks H.S., van Kleef R.G., van den Berg M., Westerink R.H. Multiple novel modes of action involved in the in vitro neurotoxic effects of tetrabromobisphenol-A. Toxicol Sci 2012, 128:235-246.
18. Heusinkveld H.J., Thomas G.O., Lamot I., van den Berg M., Kroese A.B., Westerink R.H. Dual actions of lindane (gamma-hexachlorocyclohexane) on calcium homeostasis and exocytosis in rat PC12 cells. Toxicol Appl Pharmacol 2010, 248:12-19.
19. Heusinkveld H.J., Westerink R.H. Caveats and limitations of plate reader-based high-throughput kinetic measurements of intracellular calcium levels. Toxicol Appl Pharmacol 2011, 255:1-8.
20. Hondebrink L., Meulenbelt J., Meijer M., van den Berg M., Westerink R.H. High concentrations of MDMA ('ecstasy') and its metabolite MDA inhibit calcium influx and depolarization-evoked vesicular dopamine release in PC12 cells. Neuropharmacology 2011, 61:202-208.
21. Hondebrink L., Meulenbelt J., Rietjens S.J., Meijer M., Westerink R.H. Methamphetamine, amphetamine, MDMA ('ecstasy'), MDA and mCPP modulate electrical and cholinergic input in PC12 cells. Neurotoxicology 2012, 33:255-260.
22. Hondebrink L., Meulenbelt J., Timmerman J.G., van den Berg M., Westerink R.H. Amphetamine reduces vesicular dopamine content in dexamethasone-differentiated PC12 cells only following l-DOPA exposure. J Neurochem 2009, 111:624-633.
23. Jiang H., Luan Z., Wang J., Xie J. Neuroprotective effects of iron chelator Desferal on dopaminergic neurons in the substantia nigra of rats with iron-overload. Neurochem Int 2006, 49:605-609.
24. Khvotchev M., Dulubova I., Sun J., Dai H., Rizo J., Südhof T.C. Dual modes of Munc18-1/SNARE interactions are coupled by functionally critical binding to syntaxin-1 N terminus. J Neurosci 2007, 27:12147-12155.
25. Kurkowska-Jastrzebska I., Litwin T., Joniec I., Ciesielska A., Przybylkowski A., Czlonkowski A., et al. Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease. Int Immunopharmacol 2004, 4:1307-1318.
26. Leong S.L., Cappai R., Barnham K.J., Pham C.L. Modulation of alpha-synuclein aggregation by dopamine: a review. Neurochem Res 2009, 34:1838-1846.
27. Lin M.T., Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006, 443:787-795.
28. Luk K.C., Kehm V., Carroll J., Zhang B., O'Brien P., Trojanowski J.Q., et al. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 2012, 338:949-953.
29. Obeso J.A., Rodriguez-Oroz M.C., Goetz C.G., Marin C., Kordower J.H., Rodriguez M., et al. Missing pieces in the Parkinson's disease puzzle. Nat Med 2010, 16:653-661.
30. Shafer T.J., Atchison W.D. Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: a model for neurotoxicological studies. Neurotoxicology 1991, 12:473-492.
31. Shin O.H., Rizo J., Südhof T.C. Synaptotagmin function in dense core vesicle exocytosis studied in cracked PC12 cells. Nat Neurosci 2002, 5:649-656.
32. Shulman J.M., De Jager P.L., Feany M.B. Parkinson's disease: genetics and pathogenesis. Annu Rev Pathol 2011, 6:193-222.
33. Snyder A.M., Connor J.R. Iron, the substantia nigra and related neurological disorders. Biochim Biophys Acta 2009, 1790:606-614.
34. 2+ channels coupled to exocytosis in pheochromocytoma (PC12) cells. J Neurochem 1999, 73:874-880.
35. 2+ influx pathways couple acetylcholine receptor activation to catecholamine secretion from PC12 cells. J Neurochem 2000, 75:1583-1589.
36. van der Mark M., Brouwer M., Kromhout H., Nijssen P., Huss A., Vermeulen R. Is pesticide use related to Parkinson disease? Some clues to heterogeneity in study results. Environ Health Perspect 2012, 120:340-347.
37. Westerink R.H. Exocytosis: using amperometry to study presynaptic mechanisms of neurotoxicity. Neurotoxicology 2004, 25:461-470.
38. Westerink R.H. Do we really want to REACH out to in vitro?. Neurotoxicology 2013, 39:169-172.
39. Westerink R.H., de Groot A., Vijverberg H.P. Heterogeneity of catecholamine-containing vesicles in PC12 cells. Biochem Biophys Res Commun 2000, 270:625-630.
40. Westerink R.H., Ewing A.G. The PC12 cell as model for neurosecretion. Acta Physiol (Oxf) 2008, 192:273-285.
41. 2+-induced vesicular catecholamine release from rat PC12 cells. Brain Res 2002, 957:25-36.
42. 2+. J Neurochem 2002, 80:861-873.
43. Woodman R., Lockette W. Alpha-methyltyrosine inhibits formation of reactive oxygen species and diminishes apoptosis in PC12 cells. Brain Res 2009, 1296:137-147.
44. You J.M., Yun S.J., Nam K.N., Kang C., Won R., Lee E.H. Mechanism of glucocorticoid-induced oxidative stress in rat hippocampal slice cultures. Can J Physiol Pharmacol 2009, 87:440-447.